NCT06413095 2024-05-14PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STSPresage BiosciencesPhase EARLY_PHASE1 Completed13 enrolled
NCT04541108 2024-04-18Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer TherapiesPresage BiosciencesPhase EARLY_PHASE1 Recruiting15 enrolled
NCT04891718 2022-07-08CIVO Intratumoural Microdosing of Anti-Cancer Therapies in AustraliaPresage BiosciencesPhase EARLY_PHASE1 Withdrawn
NCT00499733 2019-01-18Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase EARLY_PHASE1 Terminated19 enrolled